Radiopharm Theranostics Limited has released a press release.
RAD Doses First Patient in Second Cohort of BetaBart (RV-01)
Earlier from Radiopharm Theranostics
- Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
- RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
- Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
- RAD to meet with US FDA to align on RAD 101 Phase 3 Trial